Advertisement
Screener

Aurinia Pharmaceuticals Inc. (AUPH) Auditor

Aurinia Pharmaceuticals Inc. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-02-26: Fiscal year end 2025-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 271; Location Edmonton, Canada.
  • 2025-02-27: Fiscal year end 2024-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 271; Location Toronto, Canada.
  • 2024-02-15: Fiscal year end 2023-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 271; Location Toronto, Canada.
  • 2023-02-28: Fiscal year end 2022-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 271; Location Oakville, Canada.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-02-262025-12-31PricewaterhouseCoopers LLP271Edmonton, CanadaYes
2025-02-272024-12-31PricewaterhouseCoopers LLP271Toronto, CanadaYes
2024-02-152023-12-31PricewaterhouseCoopers LLP271Toronto, CanadaYes
2023-02-282022-12-31PricewaterhouseCoopers LLP271Oakville, CanadaYes
2022-02-282021-12-31PricewaterhouseCoopers LLP271Edmonton, CanadaYes

Similar stocks

Stock NameCountryMarket CapPE Ratio
Zai Lab Ltd (ZLAB)$2.241B-113.34
Prestige Consumer Healthcare Inc. (PBH)United States$2.163B13.03
OCULAR THERAPEUTIX, INC (OCUL)United States$2.159B-7.15
Bausch Health Companies Inc. (BHC)$2.113B-1.68
Braveheart Bio, Inc. (BRVE)United States$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Generate Biomedicines, Inc. (GENB)United States$2.052B